These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 33195606)
1. Establishment and Characterization of Canine Mammary Gland Carcinoma Cell Lines With Vasculogenic Mimicry Ability de Faria Lainetti P; Brandi A; Leis Filho AF; Prado MCM; Kobayashi PE; Laufer-Amorim R; Fonseca-Alves CE Front Vet Sci; 2020; 7():583874. PubMed ID: 33195606 [TBL] [Abstract][Full Text] [Related]
2. Pathways Involved in the Development of Vasculogenic Mimicry in Canine Mammary Carcinoma Cell Cultures. Guiraldelli GG; Prado MCM; de F Lainetti P; Leis-Filho AF; Kobayashi PE; Cury SS; Fonseca-Alves CE; Laufer-Amorim R J Comp Pathol; 2022 Apr; 192():50-60. PubMed ID: 35305714 [TBL] [Abstract][Full Text] [Related]
3. Investigation of the Prognostic Significance of Vasculogenic Mimicry and Its Inhibition by Sorafenib in Canine Mammary Gland Tumors. Prado MCM; Macedo SAL; Guiraldelli GG; de Faria Lainetti P; Leis-Filho AF; Kobayashi PE; Laufer-Amorim R; Fonseca-Alves CE Front Oncol; 2019; 9():1445. PubMed ID: 31921690 [TBL] [Abstract][Full Text] [Related]
4. Vasculogenic mimicry-associated ultrastructural findings in human and canine inflammatory breast cancer cell lines. Barreno L; Cáceres S; Alonso-Diez Á; Vicente-Montaña A; García ML; Clemente M; Illera JC; Peña L BMC Cancer; 2019 Jul; 19(1):750. PubMed ID: 31362745 [TBL] [Abstract][Full Text] [Related]
5. An Update on Molecular Pathways Regulating Vasculogenic Mimicry in Human Osteosarcoma and Their Role in Canine Oncology. Massimini M; Romanucci M; De Maria R; Della Salda L Front Vet Sci; 2021; 8():722432. PubMed ID: 34631854 [TBL] [Abstract][Full Text] [Related]
6. Establishment of three-dimensional canine osteosarcoma cell lines showing vasculogenic mimicry and evaluation of biological properties after treatment with 17-AAG. Massimini M; De Maria R; Malatesta D; Romanucci M; D'Anselmo A; Della Salda L Vet Comp Oncol; 2019 Sep; 17(3):376-384. PubMed ID: 31006970 [TBL] [Abstract][Full Text] [Related]
7. Histological, immunohistological, and ultrastructural description of vasculogenic mimicry in canine mammary cancer. Clemente M; Pérez-Alenza MD; Illera JC; Peña L Vet Pathol; 2010 Mar; 47(2):265-74. PubMed ID: 20106772 [TBL] [Abstract][Full Text] [Related]
8. Characterization of protein marker expression, tumorigenicity, and doxorubicin chemoresistance in two new canine mammary tumor cell lines. Hsiao YL; Hsieh TZ; Liou CJ; Cheng YH; Lin CT; Chang CY; Lai YS BMC Vet Res; 2014 Sep; 10():229. PubMed ID: 25267010 [TBL] [Abstract][Full Text] [Related]
9. Transcriptomic profile reveals molecular events associated to focal adhesion and invasion in canine mammary gland tumour cell lines. Cordeiro YG; Xavier PLP; Rochetti AL; Alexandre PA; Mori CMC; Strefezzi RF; Fukumasu H Vet Comp Oncol; 2018 Mar; 16(1):E89-E98. PubMed ID: 28834169 [TBL] [Abstract][Full Text] [Related]
10. Establishment and characterization of a new cell line of canine inflammatory mammary cancer: IPC-366. Caceres S; Peña L; de Andres PJ; Illera MJ; Lopez MS; Woodward WA; Reuben JM; Illera JC PLoS One; 2015; 10(3):e0122277. PubMed ID: 25807360 [TBL] [Abstract][Full Text] [Related]
11. Dickkopf-1-promoted vasculogenic mimicry in non-small cell lung cancer is associated with EMT and development of a cancer stem-like cell phenotype. Yao L; Zhang D; Zhao X; Sun B; Liu Y; Gu Q; Zhang Y; Zhao X; Che N; Zheng Y; Liu F; Wang Y; Meng J J Cell Mol Med; 2016 Sep; 20(9):1673-85. PubMed ID: 27240974 [TBL] [Abstract][Full Text] [Related]
12. Vasculogenic Mimicry in Prostate Cancer: The Roles of EphA2 and PI3K. Wang H; Lin H; Pan J; Mo C; Zhang F; Huang B; Wang Z; Chen X; Zhuang J; Wang D; Qiu S J Cancer; 2016; 7(9):1114-24. PubMed ID: 27326255 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical characterization of mammary squamous cell carcinoma of the dog. Sassi F; Sarli G; Brunetti B; Morandi F; Benazzi C J Vet Diagn Invest; 2008 Nov; 20(6):766-73. PubMed ID: 18987226 [TBL] [Abstract][Full Text] [Related]
14. Combretastatin A4 phosphate treatment induces vasculogenic mimicry formation of W256 breast carcinoma tumor in vitro and in vivo. Yao N; Ren K; Jiang C; Gao M; Huang D; Lu X; Lou B; Peng F; Yang A; Wang X; Ni Y; Zhang J Tumour Biol; 2015 Nov; 36(11):8499-510. PubMed ID: 26026583 [TBL] [Abstract][Full Text] [Related]
15. Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer. Hori A; Shimoda M; Naoi Y; Kagara N; Tanei T; Miyake T; Shimazu K; Kim SJ; Noguchi S Breast Cancer Res; 2019 Aug; 21(1):88. PubMed ID: 31387614 [TBL] [Abstract][Full Text] [Related]
16. HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells. Tang NN; Zhu H; Zhang HJ; Zhang WF; Jin HL; Wang L; Wang P; He GJ; Hao B; Shi RH World J Gastroenterol; 2014 Dec; 20(47):17894-904. PubMed ID: 25548487 [TBL] [Abstract][Full Text] [Related]
18. Five novel hormone-responsive cell lines derived from murine mammary ductal carcinomas: in vivo and in vitro effects of estrogens and progestins. Lanari C; Lüthy I; Lamb CA; Fabris V; Pagano E; Helguero LA; Sanjuan N; Merani S; Molinolo AA Cancer Res; 2001 Jan; 61(1):293-302. PubMed ID: 11196177 [TBL] [Abstract][Full Text] [Related]
19. Prognostic role of vasculogenic mimicry in colorectal cancer. Baeten CI; Hillen F; Pauwels P; de Bruine AP; Baeten CG Dis Colon Rectum; 2009 Dec; 52(12):2028-35. PubMed ID: 19934926 [TBL] [Abstract][Full Text] [Related]
20. Galectin-1 Promotes Vasculogenic Mimicry in Gastric Cancer by Upregulating EMT Signaling. You X; Liu Q; Wu J; Wang Y; Dai J; Chen D; Zhou Y; Lian Y J Cancer; 2019; 10(25):6286-6297. PubMed ID: 31772662 [No Abstract] [Full Text] [Related] [Next] [New Search]